Our Most Commonly Used Stock Pitch Deck PowerPoint Presentation Ppt Slide Template is the perfect way to pitch your stock. We have researched thousands of stock pitches and designed the most impactful way to convince your investors to invest in your equity. http://bit.ly/31JiPNj

1. Most Commonly Used
Stock Pitch Deck

2. Company Introduction
2
Catalyst Risk
› Leading market position of Hepatitis B treatments-
Product A & Product B
› Clinical trials on newer, better drugs including
Product C & Product D
› Recently announced $0.51/share dividend reveals
strong cash position and management confidence in
their business
› Uncertainty regarding Product A pricing and
Product B patent status in light of competition and
litigation with Competitor A
› Pipeline drugs may face rejection from board
› Expiring patents require improvement and approval
of new drugs to withstand growth in revenue
Recommendation: Buy Target Price: $145.09 (32% growth)
We are market leaders in hepatitis B and cancer treatment, strong cash
inflows and strong sales pipeline to craft a compelling investment that is
highly undervalued in market.
AboutUs:
Current
Price:
$109.78
This slide is 100% editable. Adapt it to your needs and capture your audience's attention.

3. Industry Outlook
3
7%
17%
11%
23%
42%
Market Share
Company A Company B Company C Company D Others
2 Sub-industries: Medical, Agricultural
› High Entry Barriers
o Due to huge initial investment
o Risk of extra time consumption
› Demand curve- Vertical
› Change in business model
o Recession - Lack of PE funding
✓ Pharmaceutical partners
✓ Internal sources
o Vertical integration- Increased profit margins
› Tight government regulation
o Increased cost for companies
Industry Trends
This graph/chart is linked to excel, and changes automatically based on data. Just left click on it and select “Edit Data”.

4. Future Industry Growth
4
0
20
40
60
80
100
120
140
160
Millions
Annual Growth
16' -19' 19' -23'
0
4
8
12
16
20
Exports Imports
Millions
16' -19' 19' -23'
Total Tax Cost
= $71-$83
Million
Biologics
Price
Competition &
Innovation Act
Mandate
= $110 Million
Profit = $15 -$25
Million
This graph/chart is linked to excel, and changes automatically based on data. Just left click on it and select “Edit Data”.
Increased Focus on Emerging Markets
Diversify Product Segment
Focus on Baby Boomers, Since they form a big share of
our customers

5. Company Overview (Template 1/2)
5
Year of establishment – 1990
Employee strength – 10,000
Catered industries – Healthcare, Insurance, Telecommunications, Utilities
Geographic presence – Different states of USA
Client base – More than 12,000 clients worldwide (Banks, Financial companies
and retailers, etc.)
Headquarters – Wisconsin, United States
Product categorization – Payments, Processing services, Risk & Compliance, Customer
& Channel Management
Revenue - $1 Billion for Year ended 30 December 2018
This slide is 100% editable. Adapt it to your needs and capture your audience's attention.

6. Company Overview (Template 2/2)
6
Background
› Add details on company’s history
› Previous line of services
› How it all started etc.
› Other key points
Capabilities
› Key services offered/Production capacity
› Milestones achieved in services offered/production
› Key projects handled
Accreditation
› List of main accreditation, if any
Company’s Vision
› This slide is 100% editable. Adapt it to your
needs and capture your audience's attention.
Company’s Mission
› This slide is 100% editable. Adapt it to your
needs and capture your audience's attention.
Promoters and Shareholding
2,022
3,184
3,476
4,621
6,168
19%
22% 23%
17%
19%
2%
9%
10%
5%
7%
0%
5%
10%
15%
20%
25%
30%
0
1,000
2,000
3,000
4,000
5,000
6,000
7,000
FY15 FY16 FY17 FY18 FY19
USDMillion
Financial Highlights
Revenue Operating Profit Margin Profit Margin
CAGR R: 32% E: 30% NI: 83%
This graph/chart is linked to excel, and changes automatically based on data. Just left click on it and select “Edit Data”.
One liner on CMD’s background :
One liner on CEO’s background
One liner of company’s key shareholder; e.g. PE investor

7. Past Acquisitions
7
Year Company Price Importance
2006 Company 1 $245 Million Respiratory Arena; Cystic Fibrosis
2006 Company 2 $2.5 billion Pulmonary Diseases
2009 Company 3 $1.7 billion Cardiovascular Franchise
2010 Company 4 $225 Million Fibrotic Diseases; Cancer
2011 Company 5 $17.2 billion Hepatitis C
2015 Company 6 $470 Million Liver Diseases
This slide is 100% editable. Adapt it to your needs and capture your audience's attention.

8. Senior Software Architect
Deforest Kelley
Add education here
Roles & Responsibilities and project undertaken
› Text Here
› Text Here
› Text Here
› Text Here
› Text Here
› Text Here
Senior Quality Assurance Engineer
William Shatner
Add education here
Roles & Responsibilities and project undertaken
› Text Here
› Text Here
› Text Here
› Text Here
› Text Here
› Text Here
Our Team (1/2)
8This slide is 100% editable. Adapt it to your needs and capture your audience's attention.

9. › Text Here
› Text Here
› Text Here
› Text Here
› Text Here
› Text Here
› Text Here
› Text Here
› Text Here
› Text Here
› Text Here
› Text Here
› Text Here
› Text Here
› Text Here
› Text Here
› Text Here
› Text Here
› Text Here
› Text Here
› Text Here
› Text Here
› Text Here
› Text Here
› Text Here
› Text Here
› Text Here
Nichelle Nichols
Technical Lead
Add education here
Leonard Nimoy
Project Manager
Add education here
Matt Kapers
Project Lead
Add education here
Our Team (2/2)
9This slide is 100% editable. Adapt it to your needs and capture your audience's attention.

10. Organizational Structure (Option 1 of 2)
10
Text Here Text Here Text Here Text Here
Text Here Text Here Text Here Text HereText Here Text Here Text Here Text Here
Text Here
This slide is 100% editable. Adapt it to your needs and capture your audience's attention.

11. John Smith
CEO
Jenny Clark
Product Manager
Elisabeth Parker
Product Manager
Marry Sweet
Product Manager
Julie Hill
Web Designer
Even Turner
Marketing
Ali Taylor
Graphic Designer
Mark Hall
Marketing
John Wood
Graphic Designer
Steven Walker
Web Designer
Anita Brown
Marketing
Peter Tucker
Web Designer
Jasmin Carter
Graphic Designer
Organizational Structure (Option 2 of 2)
11This slide is 100% editable. Adapt it to your needs and capture your audience's attention.

12. Art Director
ANITA SMITH
Text Here
Text Here
Text Here
Text Here
Personal Skills
This slide is 100% editable. Adapt it to your needs and capture your
audience's attention.
Your Text Here
This slide is 100% editable. Adapt it to your needs and capture your
audience's attention.
Your Text Here
This slide is 100% editable. Adapt it to your needs and capture your
audience's attention.
Your Text Here
Member Profile
12

13. Geographical Reach
13
Year
Founded 2016
2016 Revenue
$7.3 Billion
Approximately
560,000 Products
Number of Employees
Approximately 9,300
Over 50
countries
Approximately
200,000 customers
Over 360 Clies
Fortune 600 List
Stock
Symbol AXE
This slide is 100% editable. Adapt it to your needs and capture your audience's attention.

14. Our Services (Option 1 of 2)
14
What We Do?
Graphic
Design services
Web
Design services
Web
Development services
This slide is 100% editable. Adapt it to your needs and capture your audience's attention.

15. This slide is 100% editable. Adapt it to your needs and capture your
audience's attention.
This slide is 100% editable. Adapt it to your needs and capture your
audience's attention.
This slide is 100% editable. Adapt it to your needs and capture your
audience's attention.
This slide is 100% editable. Adapt it to your needs and capture your
audience's attention.
Digital Advertising
Marketing & Analytics
Digital Care Package
Security & Maintenance
Our Services (Option 2 of 2)
15This slide is 100% editable. Adapt it to your needs and capture your audience's attention.

16. Mobile App Showcase
16This slide is 100% editable. Adapt it to your needs and capture your audience's attention.
GPS Ability
› Your Text here
› Your Text here
› Your Text here
Fast & Furious
› Your Text here
› Your Text here
› Your Text here
Clean Coding
› Your Text here
› Your Text here
› Your Text here
Mobile Apps
› Your Text here
› Your Text here
› Your Text here
Users friendly
› Your Text here
› Your Text here
› Your Text here
E- Commerce Ability
› Your Text here
› Your Text here
› Your Text here

17. Projects in Pipeline
17
› 10 new drugs in the pipeline: 1 in NDA, 2 in phase 3, 4 in phase 2, and 3 in phase 1
› Shifting focus to oncology products, market with more than $10B in sales last year
› Notable products:
› Product 1
› Product 2
› Product 3
› Add text here
› Add Text here
› Add text here
Overview
› General Applications
› Oncology and non-oncology applications: NASH, IPF, liver fibrosis
› Add text here
› Add text here
Project Description by Product

18. Risk & Mitigation
18
Risk
Mitigation
Commercial
Competition in the cancer and
HIV franchise
Legal
Pending litigation with name 1 over
patent A; uncertainty regarding
intellectual property rights to
combination therapies
Developmental
Drugs may fail to prove efficacy in
clinical trials
Regulatory
Company may fail to secure
regulatory approval on new products
Drug from Competitor A is inferior in
many fields based on clinical data
Will most likely obtain patent
Given the company’s past
achievements, new drugs are likely to
be efficacious as well.
Will most likely obtain regulatory
approval

19. Company Valuation Analysis
19
Company
Share Price
(US$)
Market Value
(US$)
Enterprise
Value
(US$MM)
Revenue
Growth %
Current P/E NTM P/E EV/ EBITDA EV/ EBIT PEG Ratio
Company 1 153.48 116,747.60 120,436.60 7.4% 16.5 16.2 12.0 13.3 1.57
Company 2 115.88 92,553.80 92,530.40 18.1% 24.0 23.2 18.1 18.3 0.90
Company 3 182.29 36,849.70 30,052.70 92.2% 30.8 29.9 25.8 26.3 1.20
Company 4 402.40 41,293.10 40,390.10 34.0% 37.7 37.0 30.1 35.1 2.07
Company 5 391.66 91,889.10 89,163.00 87.9% 23.0 22.6 15.8 16.4 1.29
Mean 249.14 75,866.66 75,514.56 47.92% 26.4 25.78 20.36 21.88 1.41
Median 182.29 91,889.10 89,163.00 34.00% 24.0 23.2 18.1 18.3 1.29
High 402.40 116,747.60 120,436.60 92.20% 37.7 37.0 30.1 35.1 2.07
Low 115.88 36,849.70 35,052.70 7.20% 16.5 16.2 12.0 13.3 0.90
Our
Company
101.90 153,732.90 155,748.70 122.20% 10.7 10.6 8.8 8.7 0.46
This slide is 100% editable. Adapt it to your needs and capture your audience's attention.

20. DCF -valuation 2014A
Enterprise value (“EV”) 11,012
Equity value (“market cap”) 10,812
Price per share 1,08
Implied multiplies 2017A 2018E 2019E 2020E 2021E
Sales 2,4x 2,2x 2,0x 1,9x 1,8x
EBITDA 9,7x 8,7x 8,1x 7,6x 7,2x
EBIT 10,5x 9,3x 8,7x 8,1x 7,7x
Discounted Cash Flow Analysis
20
Actual Forecast period CAGR CAGR
2014A 2015A 2016A 2017A 2018E 2019E 2020E 2021E 2022E 2014-2017A 2018-2022E
Net Sales 2,955 3,568 4,102 4,663 5,036 5,388 5,711 5,997 6,237 16.4% 5.5%
Growth, % 20,7% 15,0% 13,7% 8,0% 7,0% 6,0% 5.0% 4,0%
COGS -2,098 -2,516 -2,831 -3,310 -3,544 -3,792 -4,019 -4,220 -4,389 16.4% 5.5%
Gross Profit 857 1,053 1,272 1,352 1,492 1,596 1,692 1,777 1,848 16.4% 5.5%
Margin, % 29,0% 29,5% 31,0% 29,0% 29,6% 29,6% 29,6% 29,6% 29,6%
OPEX -180 -200 -210 -215 -224 -232 -240 -249 -257 6.1% 3.5%
Growth, % 11,1% 5,0% 2,4% 4,0% 3,8% 3,6% 3,4% 3,3%
In % of net sales 6,1% 5,6% 5,1% 4,6% 4,4% 4,3% 4,2% 4,1% 4,1%
EBITDA 677 853 1,062 1,137 1,268 1,364 1,452 1,528 1,591 18.9% 5.8%
Margin, % 22,9% 23,9% 25,9% 24,4% 25,2% 25,3% 25,4% 25,5% 25,5%
Depreciation -49 -63 -75 -84 -88 -95 -100 -105 -110 19.8% 5.5%
In % of net sales 1,6% 1,8% 1,8% 1,8% 1,8% 1,8% 1,8% 1,8% 1,8%
EBIT 628 790 987 1,053 1,180 1,270 1,351 1,423 1,481 18.8% 5.9%
Tax (30%) -119 -138 -151 -164 -354 -381 -405 -427 -444 11.4% 5.9%
Capex -79 -41 -169 -115 -123 -130 -136 -142 n.a. 0
In % of net sales 2,2% 1,0% 3,6% 2,3% 2,3% 2,3% 2,3% 2,3%
Increase/Decrease in NWC -25 -5 -2 -15 -14 -13 -11 -9
Unlevered free cash flow 611 865 802 785 847 904 954 995
This slide is 100% editable. Adapt it to your needs and capture your audience's attention.

21. Base Case: $114.76 (12% Upside)
› Revenue estimates based on Bloomberg consensus; 5% revenue CAGR through 2019
› 80% gross margin; in line with historical
› 9x exit multiple, implying 3% perpetual growth
Bull Case: $135.7 (27% upside)
› Revenue Estimates Based On Bloomberg Consensus; 4% Revenue CAGR Through 2019
› 91% Gross Margin; Slight Improvement From Historical, Consistent With Analyst
Consensus
› 12x Exit Multiple, Implying 3.6% Perpetual Growth
Bear Case: $88.7 (10% downside)
› Revenue Flat in 2017 Followed by 3% CAGR Through 2019
› 85% Gross Margin; in Line with Historical
› 10x Exit Multiple, Implying 1.8% Perpetual Growth
Price Target
21This slide is 100% editable. Adapt it to your needs and capture your audience's attention.

22. 22
Additional Slides

23. Combo Chart
23
Profit(InPercentage)
0
10
20
30
40
50
60
70
80
90
100
2016 2017 2018 2019
Product 01
Product 02
Product 03
This graph/chart is linked to excel, and changes automatically based on data. Just left click on it and select “Edit Data”.

24. 24
OurMission
Goal
This slide is 100% editable. Adapt it to your needs and capture your
audience’s attention.
Vision
This slide is 100% editable. Adapt it to your needs and capture your
audience’s attention.
Mission
This slide is 100% editable. Adapt it to your needs and capture your
audience’s attention.

25. 2015
2016
2019
2018
2017
Timeline
25
2014
This slide is 100% editable. Adapt
it to your needs and capture your
audience’s attention.
This slide is 100% editable. Adapt
it to your needs and capture your
audience’s attention.
This slide is 100% editable. Adapt
it to your needs and capture your
audience’s attention.
This slide is 100% editable.
Adapt it to your needs and
capture your audience’s
attention.
This slide is 100% editable. Adapt
it to your needs and capture your
audience’s attention.
This slide is 100% editable. Adapt
it to your needs and capture your
audience’s attention.

26. Our Target
26
This slide is 100% editable. Adapt it to your
needs and capture your audience’s attention.
This slide is 100% editable. Adapt it to your
needs and capture your audience’s attention.
This slide is 100% editable. Adapt it to your
needs and capture your audience’s attention.
Target 01
This slide is 100% editable. Adapt it to your needs and capture your
audience’s attention.
Target 02
This slide is 100% editable. Adapt it to your needs and capture your
audience’s attention.
Target 03
This slide is 100% editable. Adapt it to your needs and capture your
audience’s attention.

27. 27
I choose a lazy person to do a hard
job. Because a lazy person will find
an easy way to do it.
- Bill Gates
Quotes

28. 28
ThankYou
Address
# street number, city, state
Email Address
emailaddress123@gmail.com
Contact Number
0123456789